What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Vall d'Hebron optimises a model to assay cystic fibrosis and its treatment The new protocol will help to analyse the functionality of the mutated protein in the disease and test the efficacy of drugs. News La Dra. Patricia Pozo, nova secretària honorífica de la Societat Internacional de Cefalea Per primera vegada en la història de la societat dues dones ocuparan els seus màxims càrrecs, amb la Dra. Cristina Tassorelli com a nova presidenta. News Dos professionals de Vall d’Hebron són els ambaixadors del Congrés ERS, el més important del món sobre malalties respiratòries que comença avui Els professionals són el Dr. Marc Miravitlles i la Dra. Miriam Barrecheguren, investigadors del Grup de Recerca en Pneumologia del VHIR i adjunts del Servei de Pneumologia de l'Hospital Universitari Vall d'Hebron. News El Comitè Multidisciplinari de Càncer de Pàncrees ja ha realitzat 686 avaluacions a 305 pacients El Comitè Multidisciplinari de Càncer de Pàncrees valora la situació clínica dels pacients de manera individualitzada. El 40% s'ha inclós dins un assaig clínic. News La Caixa awards one million euros to a pioneering project to reduce cardiac injury after a heart attack The project, which proposes light-controlled drugs, and in which VHIR participates, is part of the CaixaResearch Health Call 2021. News Vall d'Hebron participates in a study that shows that the prone position in non-intubated patients with severe COVID-19 improves their prognosis This major research opens the door to a change in current clinical practice to incorporate this treatment as part of the medical routine for non-intubated COVID-19 patients. News Vall d'Hebron, designat pel CatSalut com a Unitat d'Expertesa Clínica (UEC) en els àmbits de les malalties minoritàries immunitàries de l'àrea d’autoimmunes sistèmiques Vall d'Hebron ha obtingut la designació com a Unitat d'Expertesa Clínica per part de CatSalut pels àmbits de les malalties minoritàries immunitàries de l'àrea d'autoimmunes sistèmiques. News Vall d'Hebron participates in an international study that associates new genetic and immunological defects with severe COVID-19 While genetic errors are more common in younger patients, autoantibodies against type I interferons appear mainly in older patients. News Vall d'Hebron publishes the first results of a study to implement a rapid stroke treatment pathway The method proposes to transfer patients with stroke symptoms directly to the angiography room in order to reduce the time of action. News Dr. Antoni Soriano, interviewed on MedPage Today for his study that demonstrated low transmissivity of COVID-19 in children "Child-centered measures will have little impact on reducing COVID-19, and if they are too harsh they can affect the well-being of this population", says Dr. Soriano in the prestigious publication. News Vall d'Hebron tests robotic thrombectomy for stroke with a pioneering study in Europe The procedure, led by Dr. Alejandro Tomasello, aims to reduce intervention time to a minimum by working over long distances. News A study on the behaviour of Covid-19 in nursing homes shows that some comorbidities and symptoms have a strong predictive value for mortality The research conducted by the Vall d'Hebron University Hospital in cooperation with the Catalan Association of Care Resources (ACRA) analyses the effects of Covid-19 in Catalan residential centres. News “Som de ciències”, el casal d’estiu per a fills i filles de professionals de Vall d’Hebron, apropa la ciència als infants en una edició centrada en els virus “Som de ciències”, el casal d’estiu per a fills i filles de professionals de Vall d’Hebron, apropa la ciència als infants en una edició centrada en els virus News New strategies to fight aggressive breast cancer CIBER-BBN and VHIR researchers design a new system to transport a drug effective against tumour stem cells, the most resistant ones, through nanoparticles. News IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases This investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID). News Six Vall d'Hebron research groups receive grants from the Strategic Plan for Research and Innovation in Health (PERIS) The projects will investigate issues such as stroke and endometrial cancer prevention. News A new model for studying metastasis enables faster and more affordable preliminary analysis A new strategy has been developed to identify genes, drugs, and cellular pathways that regulate the metastasis process using laboratory models. News The solidarity challenge to find a cure for GNB1 encephalopathy achieves its first goal raising more than €50,000 The micro-donation initiative is being carried out by Marc León, together with the relatives of the patients, for a research project in gene therapy headed by Dr. Miguel Chillón. News Dr. María José Soler, elected editor-in-chief of the Clinical Kidney Journal Dr. María José Soler, nephrologist at Vall d'Hebron and the VHIR, will become, in June 2022, the first editor-in-chief of the specialized journal Clinical Kidney Journal. News Vall d'Hebron participates in the largest study on non-rhabdomyosarcoma type paediatric soft tissue sarcomas The pediatric surgeon Gabriela Guillén is a co-author in this study of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) that lays the foundations for the treatment of this type of tumors. Pagination First page « Previous page ‹ … Page 55 Page 56 Current page 57 Page 58 Page 59 … Next page › Last page »
